Symbol="RCKT"
AssetType="Common Stock"
Name="Rocket Pharmaceuticals Inc"
Description="Rocket Pharmaceuticals, Inc., is a cross-platform biotechnology company focused on developing gene therapies for rare and devastating pediatric diseases. The company is headquartered in Cranbury, New Jersey."
CIK="1281895"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1277940000"
EBITDA="-253559008"
PERatio="None"
PEGRatio="None"
BookValue="5.0"
DividendPerShare="0"
DividendYield="0"
EPS="-3.31"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.361"
ReturnOnEquityTTM="-0.629"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-3.31"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="52.6"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="4.072"
EVToRevenue="-"
EVToEBITDA="-6.39"
Beta="1.153"
num_52WeekHigh="24.53"
num_52WeekLow="11.78"
num_50DayMovingAverage="18.29"
num_200DayMovingAverage="19.32"
SharesOutstanding="80526000"
DividendDate="2018-01-05"
ExDividendDate="None"
symbol="RCKT"
open="15.91"
high="16.17"
low="15.79"
price="16.07"
volume="350730.00"
latest_trading_day="2023-08-29"
previous_close="15.87"
change="0.20"
change_percent="1.2602%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="45"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="55"
Volume_recent_avg="639674"
Change_recent_avg="-0.02"
Delta_recent_avg="0.85"
Variance_recent_avg="0.43"
Change_ratio_recent_avg="-0.16"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="55"
Aroon_momentum_negative="45"
image_negative_thumbnail_id_1="139"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0037.jpeg"
image_negative_thumbnail_id_2="92"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0084.jpeg"
image_neutral_thumbnail_id_1="578"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0021.jpeg"
image_neutral_thumbnail_id_2="540"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0059.jpeg"
image_positive_thumbnail_id_1="622"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0086.jpeg"
image_positive_thumbnail_id_2="643"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0065.jpeg"
image_professor_thumbnail_id_1="1169"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0003.jpeg"
image_professor_thumbnail_id_2="1198"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0032.jpeg"
